• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭:TNM 样分类。

Heart failure: TNM-like classification.

机构信息

Department of Cardiovascular, Respiratory, Nephrology, Anesthesiology and Geriatric Sciences, "Sapienza" University of Rome, Policlinico "Umberto I", Rome, Italy.

Department of Cardiovascular, Respiratory, Nephrology, Anesthesiology and Geriatric Sciences, "Sapienza" University of Rome, Policlinico "Umberto I", Rome, Italy.

出版信息

J Am Coll Cardiol. 2014 May 20;63(19):1959-60. doi: 10.1016/j.jacc.2014.02.552. Epub 2014 Mar 19.

DOI:10.1016/j.jacc.2014.02.552
PMID:24657683
Abstract

Staging of heart failure represents a major issue in clinical practice. In this setting, the MOGE(S) classification was designed to be similar to the TNM classification used in oncology. Nevertheless, MOGE(S) nosology differs greatly from the key elements of the TNM classification, as well as its simplicity and clinical applicability. In fact, MOGE(S) acronym stands for morphofunctional characteristics (M), organ involvement (O), genetic or familial inheritance pattern (G), etiological information (E), and functional status (S). Recently, a new TNM-like classification for heart failure was proposed. This classification, named HLM, refers to heart damage arising from an initial stage of impaired systolic or diastolic function, without structural injury, to an advanced stage of biventricular dysfunction (H), different stages of lung involvement (L), and malfunction of peripheral organs such as the kidney, liver, and brain (M). HLM classification was influenced by the key elements of TNM staging: simplicity, clinical usefulness, efficacy for planning a therapeutic strategy, and ability to determine patient prognosis. HLM classification seems to be easily applied in the real world and valuable for balancing economic resources with the clinical complexity of patients.

摘要

心力衰竭的分期是临床实践中的一个主要问题。在这种情况下,MOGE(S)分类旨在与肿瘤学中使用的 TNM 分类相似。然而,MOGE(S)分类学与 TNM 分类的关键要素以及其简单性和临床适用性有很大的不同。事实上,MOGE(S)缩写代表形态功能特征(M)、器官受累(O)、遗传或家族遗传模式(G)、病因信息(E)和功能状态(S)。最近,提出了一种新的心力衰竭类似 TNM 的分类。这种分类,命名为 HLM,是指由初始收缩或舒张功能障碍引起的心脏损伤,没有结构损伤,发展到双心室功能障碍的晚期(H)、不同阶段的肺受累(L),以及肾脏、肝脏和大脑等外周器官的功能障碍(M)。HLM 分类受到 TNM 分期的关键要素的影响:简单性、临床实用性、制定治疗策略的疗效以及确定患者预后的能力。HLM 分类似乎易于在现实世界中应用,对于平衡经济资源与患者的临床复杂性具有重要价值。

相似文献

1
Heart failure: TNM-like classification.心力衰竭:TNM 样分类。
J Am Coll Cardiol. 2014 May 20;63(19):1959-60. doi: 10.1016/j.jacc.2014.02.552. Epub 2014 Mar 19.
2
The MOGE(S) classification for cardiomyopathies: current status and future outlook.心肌疾病的 MOGE(S)分类:现状与展望。
Heart Fail Rev. 2017 Nov;22(6):743-752. doi: 10.1007/s10741-017-9641-4.
3
The MOGE(S) classification : A TNM-like classification for cardiomyopathies.MOGE(S) 分类:一种类似于TNM的心肌病分类方法。
Herz. 2016 Sep;41(6):503-6. doi: 10.1007/s00059-015-4394-0. Epub 2016 Jan 25.
4
The MOGE(S) classification of cardiomyopathy for clinicians.心肌病的 MOGE(S)分类——临床医生视角
J Am Coll Cardiol. 2014 Jul 22;64(3):304-18. doi: 10.1016/j.jacc.2014.05.027.
5
The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation.心肌病表型 - 基因型命名的MOGE(S)分类:得到世界心脏联盟认可。
J Am Coll Cardiol. 2013 Dec 3;62(22):2046-72. doi: 10.1016/j.jacc.2013.08.1644. Epub 2013 Nov 18.
6
Cardiomyopathies: MOGE(S): a standardized classification of cardiomyopathies?心肌病:MOGE(S):一种心肌病的标准化分类方法?
Nat Rev Cardiol. 2014 Mar;11(3):134-5. doi: 10.1038/nrcardio.2013.219. Epub 2014 Jan 14.
7
The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: more questions than answers?心肌病表型-基因型命名的MOGE(S)分类:问题比答案更多?
J Am Coll Cardiol. 2014 Jun 17;63(23):2584. doi: 10.1016/j.jacc.2014.01.078. Epub 2014 Apr 23.
8
Reply: The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: more questions than answers?回复:心肌病表型 - 基因型命名法的MOGE(S)分类:问题多于答案?
J Am Coll Cardiol. 2014 Jun 17;63(23):2584-2586. doi: 10.1016/j.jacc.2014.03.028. Epub 2014 Apr 23.
9
Nomenclature and systems of classification for cardiomyopathy in children.儿童心肌病的命名和分类系统
Cardiol Young. 2015 Aug;25 Suppl 2:31-42. doi: 10.1017/S1047951115001201.
10
MOGE(S) nosology in low-to-middle-income countries.中低收入国家的MOGE(S)分类法
Nat Rev Cardiol. 2014 May;11(5):307. doi: 10.1038/nrcardio.2013.219-c1. Epub 2014 Mar 25.

引用本文的文献

1
Assessing the TNM Classification for Periprosthetic Joint Infections of the Knee: Predictive Validity for Functional and Subjective Outcomes.评估膝关节假体周围感染的TNM分类:对功能和主观结果的预测效度
J Pers Med. 2025 Jan 10;15(1):24. doi: 10.3390/jpm15010024.
2
Strategy for an early simultaneous introduction of four-pillars of heart failure therapy: results from a single center experience.早期同时引入心力衰竭治疗四支柱策略:单中心经验结果。
Am J Cardiovasc Drugs. 2024 Sep;24(5):663-671. doi: 10.1007/s40256-024-00660-6. Epub 2024 Jun 23.
3
Prognostic Assessment of HLM Score in Heart Failure Due to Ischemic Heart Disease: A Pilot Study.
缺血性心脏病所致心力衰竭中HLM评分的预后评估:一项初步研究。
J Clin Med. 2024 Jun 4;13(11):3322. doi: 10.3390/jcm13113322.
4
The role and application of current pharmacological management in patients with advanced heart failure.当前药物治疗在晚期心力衰竭患者中的作用及应用
Heart Fail Rev. 2024 Mar;29(2):535-548. doi: 10.1007/s10741-024-10383-0. Epub 2024 Jan 29.
5
Heart failure 'the cancer of the heart': the prognostic role of the HLM score.心力衰竭是“心脏的癌症”:HLM 评分的预后作用。
ESC Heart Fail. 2024 Feb;11(1):390-399. doi: 10.1002/ehf2.14594. Epub 2023 Nov 27.
6
Heart Failure Pharmacological Management: Gaps and Current Perspectives.心力衰竭的药物治疗:差距与当前观点。
J Clin Med. 2023 Jan 28;12(3):1020. doi: 10.3390/jcm12031020.
7
Levosimendan in Europe and China: An Appraisal of Evidence and Context.欧洲和中国的左西孟旦:证据与背景评估
Eur Cardiol. 2021 Nov 8;16:e42. doi: 10.15420/ecr.2021.41. eCollection 2021 Feb.
8
Sodium-glucose cotransporter 2 inhibitors and heart failure: the best timing for the right patient.钠-葡萄糖共转运蛋白 2 抑制剂与心力衰竭:为合适的患者选择最佳时机。
Heart Fail Rev. 2023 May;28(3):709-721. doi: 10.1007/s10741-021-10170-1. Epub 2021 Oct 16.
9
Myocardial Tissue Characterization in Heart Failure with Preserved Ejection Fraction: From Histopathology and Cardiac Magnetic Resonance Findings to Therapeutic Targets.心力衰竭伴射血分数保留的心肌组织特征化:从组织病理学和心脏磁共振成像结果到治疗靶点。
Int J Mol Sci. 2021 Jul 17;22(14):7650. doi: 10.3390/ijms22147650.
10
Heart failure: role and point of view of cardiac intensivist.心力衰竭:心脏重症专家的角色与观点
Cardiovasc Diagn Ther. 2021 Feb;11(1):301-308. doi: 10.21037/cdt-20-339.